ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,150.93
-0.39%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,436.755
0.60%
Brent Oil
83.65
-0.82%
Bitcoin
62,706.78
-3.31%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Onyx Pharmaceuticals, Inc. (MM) (ONXX)

  7. Onyx Pharmaceuticals, Inc. (MM) (ONXX) News

Onyx Pharmaceuticals, Inc. (MM) (ONXX)

Onyx Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONXX
DateTimeSourceHeadlineSymbolCompany
21/07/201014:00PR Newswire (US)Onyx Pharmaceuticals Initiates a Phase 3 Carfilzomib Combination Trial in Relapsed Multiple MyelomaNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
14/07/201021:43Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
15/06/201016:57Dow Jones NewsCORRECT (6/14): Bayer Drug Fails To Extend Lung Cancer Patients' LivesNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
14/06/201015:17Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Rise On European Economic OptimismNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
14/06/201012:00PR Newswire (US)Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on NexavarNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
14/06/201011:45Dow Jones NewsUPDATE: Bayer Drug Fails To Extend Lung Cancer Patients' LivesNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
14/06/201011:03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
14/06/201007:40PR Newswire (US)Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on NexavarNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
14/06/201007:31PR Newswire (US)Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall SurvivalNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
09/06/201012:00PR Newswire (US)S*BIO Completes Enrollment of Patients in Phase 2 Clinical Trials for its JAK2 Inhibitor SB1518NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
08/06/201021:00PR Newswire (US)Onyx Pharmaceuticals to Present at the Goldman Sachs 31st Annual Global Healthcare ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
08/06/201014:00PR Newswire (US)Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at the 15th Congress of the European Hematology AssociationNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
05/06/201022:30PR Newswire (US)Onyx Pharmaceuticals' Carfilzomib Continues to Demonstrate Encouraging Results in Ongoing Phase 2 Multiple Myeloma StudyNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
04/06/201020:00PR Newswire (US)Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination TrialNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/06/201014:00PR Newswire (US)Onyx Pharmaceuticals Initiates Phase 1 Study of Oral Proteasome Inhibitor in Advanced Solid TumorsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/05/201023:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/05/201023:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/05/201023:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/05/201023:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/05/201023:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/05/201023:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/05/201022:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
28/05/201021:40Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/05/201001:30Dow Jones NewsUK's NICE Rejects Bayer's Appeal For Nexavar; Says Costs Too HighNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
24/05/201021:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
21/05/201016:44PR Newswire (US)/C O R R E C T I O N -- Onyx Pharmaceuticals, Inc./NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
20/05/201023:01PR Newswire (US)Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual MeetingNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
20/05/201023:01PR Newswire (US)Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 46th American Society of Clinical Oncology Annual MeetingNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
11/05/201021:00PR Newswire (US)Onyx Pharmaceuticals to Present at the Baird 2010 Growth Stock ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
05/05/201021:00PR Newswire (US)Onyx Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ONXX

Your Recent History

LSE
TIP5
Ishs $ Tps 0-5
LSE
0ROQ
Comet
NASDAQ
HAYZ
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved